Chanchlani N, Lin S, Auth MK, Lee CL, et al. Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: Results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study. Aliment Pharmacol Ther 2022 Aug 29. doi: 10.1111/apt.17170.
PMID: 36039036